带有黑激素的丝纤维素微针用于昼夜节律调节
Xiaoyue Li1, Yanai Chen1, Huiyan Shao1
1National Engineering Laboratory for Modern Silk, College of Textile and Clothing Engineering, Soochow University, Suzhou, Jiangsu 215123, China.
International journal of biological macromolecules
|February 1, 2025
概括
丝纤维素微针有效地释放黑激素,提供长达11小时的持续释放. 这些新型的微针在通过稳定血液中药物度来治疗失眠和焦虑方面表现有前途.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 药理学 药理学是指药理学的学科.
背景情况:
- 微针代表了一种先进的透皮药物输送方法,增强了药物的生物可用性和患者的坚持.
- 丝纤维素为微针制造提供了独特的基材,因为其SILK I晶体结构,提供机械强度和受控的胀.
研究的目的:
- 开发和评估含有黑激素的丝纤维蛋白微针,用于通过皮肤持续释放.
- 为了研究药物加载和释放动力学之间的相关性.
- 评估黑色素微针对于失眠和焦虑的体内疗效.
主要方法:
- 制造带有黑素的丝纤维微针.
- 在体外通过皮肤释放药物的研究中,以确定释放概况和动力学.
- 用动物模型进行体内研究,以评估药理动力学和药理动力学.
主要成果:
- 梅拉托尼丝纤维蛋白微针显示持续释放,1毫克/片装载达到11小时释放和超过85%的累积释放.
- 在体内实验显示,血中黑激素度在长达8小时内保持稳定.
- 药理动力学研究证实了在模型大鼠中对失眠和焦虑有显著的治疗效果.
结论:
- 含有黑色素的丝纤维蛋白微针提供了一种有效的透皮持续释放系统.
- 这些微针为治疗失眠和焦虑症提供了一个有前途的治疗策略.
- 药物负载显著影响持续释放时间和疗效.
相关概念视频
Management of Insomnia
229
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
229
Sedatives and Hypnotics Drugs: Miscellaneous Agents
144
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
144


